Abstract
BackgroundFour months after SARS-CoV-2 infection, 22%–50% of COVID-19 patients still experience complaints. Long COVID is a heterogeneous disease and finding subtypes could aid in optimising and developing treatment for the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have